跳至主要内容
临床试验/NL-OMON22197
NL-OMON22197招募中不适用

ASSESSMENT OF THE PERFORMANCE OF THE SECOND GENERATION PILLCAM COLON CAPSULE (PCCE 2) IN CROHN‘S DISEASE BEFORE AND AFTER TREATMENT WITH ANTI-TNF

Academic Medical Center, Amsterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Active ileocolonic Crohn’s disease with CDAI > 150 points
  • - Elevated faecal calprotectin >250 ug/g and/or increased CRP levels (> 5 mg/l)

排除标准

  • - Any contraindication for colon capsule examination including swallowing disorders, severe congestive heart failure, renal insufficiency, or co-morbities contraindicating these procedures.
  • - More than 1 bowel resection for CD

研究者

发起方
Academic Medical Center, Amsterdam

相似试验